NAFLD and CKD share common risk factors and therefore both liver and kidney injury may be driven by obesity-associated mechanisms of disease, including lipotoxicity, oxidative stress, enhanced pro-inflammatory cytokine, and renin-angiotensin-aldosterone system (RAAS) axis activation [10],[77]–[80]. This evidence concerns the gene REN and metabolic dysfunction-associated steatotic liver disease.